Glaser Daniel S 4

What Happened
Daniel S. Glaser, a non-management director of MetLife, received 587 shares on 2026-06-16 as part of director compensation. The shares were valued at $87.40 each, for a total grant value of $51,304. This was an award/acquisition (code A), not an open-market purchase or sale; the director elected to defer receipt under MetLife’s Deferred Compensation Plan and the shares are held in a GRAT.

Key Details

• Transaction date: 2026-06-16
• Filing date (Form 4): 2026-06-18 (filed within the SEC’s two-business-day window)
• Shares: 587 at $87.40 per share — aggregate value $51,304
• Transaction code: A (award/grant/other acquisition)
• Shares owned after transaction: Not specified in this filing
• Footnotes: F1 — director retainer fees paid in MetLife stock and deferred under the MetLife Deferred Compensation Plan for Non-Management Directors. F2 — the shares are held in a GRAT (Grantor Retained Annuity Trust).

Context
This transaction reflects routine director compensation (stock retainer) that was deferred for tax/estate-planning purposes and placed into a GRAT. Such awards are standard compensation and do not carry the same market-signaling weight as an open-market purchase or sale by an insider.